Skip to content

Change in Prepaids at other companies

Celcuity logo
CelcuityCELC
-$3.52M-266%
GRAIL, Inc. logo
GRAIL, Inc.GRAL
$2.12M+175%

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s change in prepaids.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s change in prepaids?
Relay Therapeutics, Inc. (RLAY) reported change in prepaids of -$7.36M in Q1 2026.
How has Relay Therapeutics, Inc.'s change in prepaids changed year-over-year?
Relay Therapeutics, Inc.'s change in prepaids decreased by 287.3% year-over-year, from $3.93M to -$7.36M.
What does change in prepaids mean?
Captures the net change in payments made in advance for goods or services that will be consumed in future periods. An increase in this balance typically indicates higher cash outflows for upcoming operational needs, while a decrease suggests the recognition of previously paid expenses. It is a key component in reconciling net income to cash flow from operations.